课题基金 / 基金详情

Antibacterial and anti-inflammatory activities of Parotid Secretory Protein

Antibacterial and anti-inflammatory activities of Parotid Secretory Protein
腮腺分泌蛋白的抗菌和抗炎活性
批准号:
8468676
负责人:
SVEN-ULRIK GORR
金额:
$33.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-22 至 2015-05-31

项目摘要

项目成果

SVEN-ULRIK GORR的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):该项目的长期目标是确定腮腺分泌蛋白(PSP;SPLuc2)是否是口腔中的一种双功能宿主防御蛋白。PSP在唾液腺、口腔上皮细胞和唾液中表达,但其功能尚不清楚。细菌和肿瘤坏死因子上调PSP的表达,蛋白质结构分析表明其可能类似于杀菌/通透性增加蛋白(BPI)和内毒素结合蛋白(LBP)。根据这两种蛋白中活性区域的位置,设计了几种PSP多肽,发现它们在体内和体外都具有抗菌和抗内毒素活性。根据这些PSP多肽的初步结果和完整PSP的其他初步数据,推测PSP多肽的双重抗菌和抗炎活性反映在完整PSP蛋白的生物活性上。两个具体目标将检验PSP拟议的功能。目的1研究PSP的抗菌活性。PSP多肽和重组PSP将用于生化、细胞生物学和体内实验,以确定PSP是否具有抑菌或杀菌活性、细菌凝集和抑制生物被膜形成。目的2研究PSP的抗炎活性。PSP多肽和重组PSP将用于生化、细胞生物学和体内实验,以确定PSP是否在体外结合内毒素,阻断内毒素的作用,并在内毒素诱导的脓毒症模型中保护小鼠。如果得到证实,PSP的拟议功能将扩大在口腔中表达并参与口腔粘膜防御的抗微生物宿主防御蛋白的种类。因此,这里提出的研究将为未来旨在对抗感染和控制炎症的新临床方法的转译研究奠定基础。
英文摘要
DESCRIPTION (provided by applicant): The long-term goal of this project is to determine if Parotid Secretory Protein (PSP; SPLUNC2) is a dual function host-defense protein in the oral cavity. PSP is expressed in salivary glands, oral epithelial cells and saliva but its function is unknown. Expression of PSP is up-regulated by bacteria and TNF and an in silico structural analysis of PSP revealed that it may be similar to bactericidal/permeability increasing protein (BPI) and LPS-binding protein (LBP). Guided by the location of active domains in these two proteins, several PSP peptides were designed and found to exhibit both antibacterial and anti-endotoxin activities in vitro and in vivo. Based on these initial results with PSP peptides and additional preliminary data for intact PSP it is hypothesized that the dual- function antibacterial and anti-inflammatory activities detected for PSP peptides are reflected in the biological activity of the intact PSP protein. Two specific aims will test the proposed functions of PSP. Aim 1 will characterize the antibacterial activity of PSP. PSP peptides and recombinant PSP will be used in biochemical, cell biological and in vivo experiments to determine if PSP exhibits bacteriostatic or bactericidal activity, bacterial agglutination, and inhibition of biofilm formation. Aim 2 will characterize the anti- inflammatory activity of PSP. PSP peptides and recombinant PSP will be used in biochemical, cell biological and in vivo experiments to determine if PSP binds LPS, blocks the action of LPS in vitro and protects mice in an LPS-induced sepsis model. If confirmed, the proposed functions of PSP will expand the group of antimicrobial host- defense proteins that are expressed in the oral cavity and participate in the defense of the oral mucosa. Thus, the research proposed here will lay the foundation for future translational research aimed at novel clinical approaches to combat infection and control inflammation.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.peptides.2012.03.017
发表时间: 2012-06
期刊: Peptides
影响因子: 3
作者: [Abdolhosseini M, Nandula SR, Song J, Hirt H, Gorr SU]
通讯作者: Gorr SU
DOI: 10.1007/s11010-011-0991-2
发表时间: 2012-01
期刊: MOLECULAR AND CELLULAR BIOCHEMISTRY
影响因子: 4.3
作者: [Abdolhosseini, Mahsa, Sotsky, Julie B., Shelar, Anuradha P., Joyce, Paul B. M., Gorr, Sven-Ulrik]
通讯作者: Gorr, Sven-Ulrik
DOI: 10.1371/journal.pone.0194900
发表时间: 2018
期刊: PloS one
影响因子: 3.7
作者: [Hirt H, Hall JW, Larson E, Gorr SU]
通讯作者: Gorr SU
DOI: 10.1016/j.actbio.2013.06.017
发表时间: 2013-09
期刊: ACTA BIOMATERIALIA
影响因子: 9.7
作者: [Holmberg, Kyle V., Abdolhosseini, Mahsa, Li, Yuping, Chen, Xi, Gorr, Sven-Ulrik, Aparicio, Conrado]
通讯作者: Aparicio, Conrado
Antibacterial and anti-inflammatory activities of Parotid Secretory Protein
  • 批准号:
    8269569
  • 项目类别:
  • 资助金额:
    $34.82万
  • 财政年份:
    2010
  • 负责人:
    SVEN-ULRIK GORR
  • 依托单位:
Antibacterial and anti-inflammatory activities of Parotid Secretory Protein
  • 批准号:
    8097392
  • 项目类别:
  • 资助金额:
    $34.11万
  • 财政年份:
    2010
  • 负责人:
    SVEN-ULRIK GORR
  • 依托单位:
Systems Approach to Sjogren's Syndrome Pathogenesis (SASSP)
Systems Approach to Sjogren's Syndrome Pathogenesis (SASSP)
海外基金